SLU-PP-332 is a synthetic pan-agonist of estrogen-related receptors (ERRα, ERRβ, ERRγ), developed to mimic the metabolic effects of endurance exercise. By activating these receptors, particularly ERRα, SLU-PP-332 enhances mitochondrial biogenesis, increases fatty acid oxidation, and shifts energy metabolism towards improved efficiency. Preclinical studies in mice have demonstrated significant improvements in endurance, weight reduction, and muscle function, positioning SLU-PP-332 as a promising candidate for addressing metabolic disorders and promoting overall metabolic health .
| Weight | 250mcg |
|---|---|
| Quantity | Each bottle contains 100 pills |
10 in stock
Exercise-Mimetic Properties – Activates pathways that replicate the benefits of endurance training, enhancing physical performance without actual exercise .
Enhances Mitochondrial Function – Promotes mitochondrial biogenesis and efficiency, leading to increased energy production at the cellular level .
Promotes Fatty Acid Oxidation – Shifts energy metabolism towards increased fat utilization, aiding in weight management and metabolic health .
Improves Muscle Endurance – Increases oxidative muscle fibers and endurance capacity, contributing to better muscle performance .
Potential Therapeutic Applications – Shows promise in treating metabolic disorders, obesity, and age-related decline by improving metabolic pathways .
All products offered on this website are strictly intended for research and development purposes only. They are not for human consumption in any form.
The statements presented on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
Superhuman Peptides operates solely as a chemical supplier. It is not a compounding pharmacy or a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Superhuman Peptides is also not an outsourcing facility as defined under Section 503B of the same Act.
This website contains information about supplementary products. By entering, you confirm that you are of legal age (18 years or older) to access this information. If you are not of legal age, please leave this site immediately.
